Apr 1 |
Solid Biosciences gets FDA rare pediatric disease status for DMD therapy
|
Apr 1 |
Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
|
Mar 28 |
How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback
|
Mar 28 |
William Blair starts Solid Biosciences at outperform
|
Mar 27 |
Solid Biosciences to Participate at Cantor’s Virtual Muscular Dystrophy Symposium
|
Mar 15 |
Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
|
Mar 13 |
Piper Sandler upgrades Solid Biosciences to overweight
|
Mar 13 |
Solid Biosciences files $300M mixed securities shelf
|
Mar 13 |
Solid Biosciences reports Q4 results
|
Mar 13 |
Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results
|